Influenza Vaccine Market to Reach $17.41 Billion by 2035, Growing at 7.72% CAGR | Sanofi, GSK, Pfizer Lead Global Competition
PUBLISHED Tuesday, April 28, 2026 · roots analysis
AI BRIEFING
- ⬤ The global influenza vaccine market is expected to reach $17.41 billion by 2035, growing at a 7.72% CAGR.
- ⬤ Sanofi, GlaxoSmithKline (GSK), and Pfizer are leading the global competition.
- ⬤ Seasonal flu infects roughly 5-10% of the global population each year.
ADVERTISEMENT